Search PubMed⌕ Search

PubMed · 10504433

Robust QTL effect estimation using the minimum distance method.

Abstract

Robustness has received little attention in QTL studies. We compare Maximum Likelihood (ML) and the Minimum Distance (MD) methods when there exists data contamination caused by outliers. A backcross population of size (N) 200 and 500 and 0, 5 or 25 outliers was simulated. The mean and standard deviation of the first QTL genotype were set to 1. Four cases were considered: (i) micro2=1, sigma2=1; (ii)micro2=1, sigma2=1.25; (iii) micro2=1.252, sigma2=1; (iv) micro2=1.282, sigma2=1.25, where micro2 and sigma2 are the mean and standard deviation of the second genotype. Either full or selective genotyping was considered. A Monte Carlo MD method is proposed to deal with missing genotypes. MD estimates were much more robust than ML estimates, especially with respect to scale parameter estimates, and with selective genotyping.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M Pérez-Enciso, M A Toro. 1999. Robust QTL effect estimation using the minimum distance method.. https://doi.org/10.1038/sj.hdy.6885800

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Hepatitis C virus genotypes. Study of 302 patients coinfected by the human immunodeficiency virus].

BACKGROUND: To study the distribution of different HCV genotypes in HIV-infected patients. PATIENTS AND METHOD: This study was carried out in 302 HIV/HCV-coinfected patients who were followed-up at the HIV/AIDS Unit of the Arnau de Vilanova University Hospital of Lleida (Spain). HCV genotypes were determined by Inno-Lipa HCV II technique (Innogenetics, Belgium). RESULTS: 143 patients (51.43%) had a genotype-1, followed by genotype-3 (81 patients; 29.13%), genotype-4 (53 patients; 19.06%), and genotype-2 (one patient; 0.35%). It was not possible to know the genotype in 24 patients (NT). CONCLUSIONS: In our health care area, HCV genotype-1 was the commonest among HIV/HCV-coinfected patients. However, a given HIV-infected patient with HCV antibodies has practically the same probability of having a genotype-1 as a genotype non-1.

Genotype↗

Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States.

CONTEXT: Population-based estimates of the prevalence of disease-associated mutations, such as hemochromatosis (HFE) gene mutations, are needed to determine the usefulness of genetic screening. OBJECTIVE: To estimate the prevalence of the HFE mutations C282Y and H63D in the US population. DESIGN: Cross-sectional population-based study of samples in the DNA bank from phase 2 of the Third National Health and Nutrition Examination Survey conducted from 1992 to 1994. SETTING AND PARTICIPANTS: Genotyped samples of cells from a total of 5171 participants, cross-classified by sex, age, and race/ethnicity in the analysis. MAIN OUTCOME MEASURES: Estimates of the prevalence of C282Y and H63D mutations. RESULTS: The prevalence of C282Y homozygosity is estimated to be 0.26% (95% confidence interval [CI], 0.12%-0.49%); 1.89% (95% CI, 1.48%-2.43%) for H63D homozygosity; and 1.97% (95% CI, 1.54%-2.49%) for compound heterozygosity. The prevalence estimates for C282Y heterozygosity (C282Y/wild type) are 9.54% among non-Hispanic whites, 2.33% among non-Hispanic blacks, and 2.75% among Mexican-Americans. The prevalence estimates of the C282Y mutation in the US population are 5.4% (95% CI, 4.7%-6.2%) and 13.5% (95% CI, 12.5%-14.8%) for the H63D mutation. CONCLUSIONS: Estimates of prevalence of HFE mutations are within the expected range for non-Hispanic whites and blacks but the estimated prevalence of the C282Y mutation among Mexican-Americans is less than expected. Mutation data now need to be linked to clinically relevant indices, such as transferrin saturation level.

Genotype↗